STEPHENS INC /AR/ - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 320 filers reported holding GW PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
STEPHENS INC /AR/ ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$1,040,000
+81.8%
4,794
-3.3%
0.02%
+70.0%
Q4 2020$572,000
+106.5%
4,958
+74.0%
0.01%
+100.0%
Q3 2020$277,000
-0.7%
2,850
+25.2%
0.01%
-16.7%
Q2 2020$279,000
+23.5%
2,277
-11.6%
0.01%0.0%
Q1 2020$226,000
-30.7%
2,577
-17.3%
0.01%
-14.3%
Q4 2019$326,000
-10.2%
3,117
-1.3%
0.01%
-12.5%
Q3 2019$363,000
-21.1%
3,157
+18.4%
0.01%
-20.0%
Q2 2019$460,000
+2.7%
2,667
+0.4%
0.01%
-9.1%
Q1 2019$448,000
-23.7%
2,657
-55.9%
0.01%
-35.3%
Q4 2018$587,0006,0260.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders